Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients

Transplantation Proceedings

Volumn 44, Issue 1, 2012, Pages 101-108

  Pamugas, G E P ^a   Danguilan, R A ^a   Lamban, A B ^a   Mangati, V B ^a   Ona, E T ^a  

^a National Kidney and Transplant Institute Philippines   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ARPIMUNE; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN; CYCLOSPORIN A; ISONIAZID; MYCOPHENOLIC ACID; NYSTATIN; PREDNISONE; UNCLASSIFIED DRUG; VALACICLOVIR;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ADULT; ANEMIA; ANTIBIOTIC PROPHYLAXIS; AREA UNDER THE CURVE; BIOEQUIVALENCE; CHICKENPOX; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DENGUE; DIABETES MELLITUS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTRITIS; GENITAL TRACT INFECTION; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HERPES SIMPLEX; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRANSAMINASEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MAXIMUM PLASMA CONCENTRATION; MORTALITY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SYSTOLIC HYPERTENSION; THRUSH; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT DURATION; TREATMENT WITHDRAWAL; TUBERCULOSIS; URINARY TRACT INFECTION;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CYCLOSPORINE; DRUG MONITORING; DRUGS, GENERIC; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LINEAR MODELS; MALE; MIDDLE AGED; PHILIPPINES; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84858718267     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.12.002     Document Type: Conference Paper

References (7)

1. D. Attaneo, N. Perico, G. Remuzzi Generic cyclsoporine formulations: more open questions than answers Transpl Int 18 2005 371
2. S. Pollard, B. Nashan, A. Johnston A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporine A: a consensus statement Clin Ther 25 2003 1654
3. CTS Collaborative Study Newsletter 1, 2001 http://www.ctstransplant.org/ public/newsletters/2001/gif/2001-1.html Accessed January 19, 2008
4. A. Sharma, C. Shekhar, M. Heer Comparison of generic cyclosporine microemulsion verus neoral in de novo renal transplant recipients managed by 2-hour postdose monitoring Transplant Proc 38 2006 2051
5. K. Mahalati, P. Belitsky, I. Sketris Neoral monitoring by sparse sampling area under the concentration time curve Transplantation 68 1999 55
6. A. Lamban, B. Padilla, D. Bayog Cyclosporine neoral monitoring among kidney transplant patients: a pilot study NKTI Proc 5 2003 32
7. J. Kurtkoti, V. Sakhuja, K. Sud The utility of 1 and 3 month protocol biopsies on renal allograft function: a randomized controlled study Am J Transplant 8 2008 317